BioSpace News Archive

Catamaran Bio , Inc. today announced the appointment of Michael DeRidder, PhD, as Senior Vice President, Corporate Strategy and New Product Planning.

Element Biosciences Inc. today announced a partnership with Fabric Genomics Inc. to explore commercialization of end-to-end clinical application solutions based on Element’s AVITI system and the Fabric Enterprise clinical interpretation platform.

Avinger, Inc., a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease, announced that physicians in the U.S. have successfully completed first cases with its new Lightbox 3 imaging console.

Instrumems announced its formal entry into the flow sensor market with a breakthrough solution that offers multi-sense capabilities.

Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it will work with Inhibrx in an effort to develop a predictive biomarker for INBRX-109 in solid tumors.

Sesen Bio (Nasdaq: SESN ), a late-stage clinical company developing targeted fusion protein therapeutics for the t

Masimo (NASDAQ: MASI) announced today the FDA clearance of SedLine® brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor.

Acasti Pharma Inc. today recognizes and celebrates Rare Disease Day (February 28), as established by the European Organisation for Rare Diseases.

Minerva Neurosciences, Inc. today announced that results from the Phase 3 clinical trial of roluperidone to treat negative symptoms in patients with schizophrenia have been published in Schizophrenia Bulletin.

Antares Pharma, Inc. today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to virtually present and host investor meetings at the Cowen 42nd Annual Healthcare Conference being held on March 7-9, 2022.